Orion Oyj A
Research Orion Oyj A (ORNAV) on Bullrun: market cap EUR 10.93B, P/E 18.6, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerORNAV
- ExchangeHE
- CountryFinland
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 10.93B
- P/E18.6
- Dividend yield2.2%
- Financial periodQ2 2026
- RevenueEUR 521.60M
- Net incomeEUR 140.20M
- Free cash flowEUR 255.90M
- Gross margin65.2%
Valuation Snapshot
latest market cap is EUR 10.93B; P/E is 18.6; dividend yield is 2.2%.
Peer valuation comparison
Latest P/E is 18.56x versus a Healthcare sector median of 24.46x (24.1% below).
Latest dividend yield is 2.17% versus a Healthcare sector median of 2.11% (2.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-13 | EUR 10.93B | 18.6 | 2.3% | 1.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.8 EUR, yield 2.2%.
About Orion Oyj A
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. It offers pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflammatory pain; Divina series for menopausal symptoms; Simdax for acute decompensated heart failure; Fareston for breast cancer;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Orion Oyj A's market cap?
Orion Oyj A's market capitalization is EUR 10.93B.
What is Orion Oyj A's P/E ratio?
Orion Oyj A's price-to-earnings (P/E) ratio is 18.6.
Does Orion Oyj A pay a dividend?
Orion Oyj A has a dividend yield of 2.2%.
What does Orion Oyj A do?
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.